Optimizing Benefit Design and Implementation for Improved PDT Access

EP: 1.Differentiating PDTs from Wellness Apps and Evaluating Efficacy

EP: 2.Payer Needs and Strategies for Evaluating and Covering PDTs

EP: 3.Payers Review Process and Effective Strategies for PDT Coverage

EP: 4.Stakeholder Involvement and Evidence Requirements for PDT Coverage Decisions

EP: 5.Dawn of the Age of Adopting PDTs

EP: 6.Identifying the Most Impactful Disease Areas and Patient Populations for PDTs

EP: 7.Evolving Commercialization and Distribution Models for PDTs

EP: 8.Promoting Appropriate PDT Prescribing Through Provider Education and Support

EP: 9.Optimizing Provider Education, Utilization Monitoring, and Value-Based Contracts for PDTs

Now Viewing

EP: 10.Optimizing Benefit Design and Implementation for Improved PDT Access

EP: 11.PDTs' Role in Addressing Health Care Disparities and Priorities for Improving PDT Access

Video content above is prompted by the following questions:

• How do payers determine the optimal pharmacy vs. medical benefit design to cover prescription digital therapeutics (PDTs) to enhance patient access and adoption?
  • What factors and considerations went into the decision to cover a particular PDT through the pharmacy benefit versus the medical benefit, and why was that pathway determined to be optimal for that specific PDT?
• What characteristics and factors did Mass Health consider when selecting clinics to prescribe and implement the use of prescription digital therapeutics?